188 related articles for article (PubMed ID: 32532213)
1. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
[TBL] [Abstract][Full Text] [Related]
2. Five-year trajectories of multimorbidity patterns in an elderly Mediterranean population using Hidden Markov Models.
Violán C; Fernández-Bertolín S; Guisado-Clavero M; Foguet-Boreu Q; Valderas JM; Vidal Manzano J; Roso-Llorach A; Cabrera-Bean M
Sci Rep; 2020 Oct; 10(1):16879. PubMed ID: 33037233
[TBL] [Abstract][Full Text] [Related]
3. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
[TBL] [Abstract][Full Text] [Related]
4. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
6. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients.
Guisado-Clavero M; Violán C; López-Jimenez T; Roso-Llorach A; Pons-Vigués M; Muñoz MA; Foguet-Boreu Q
BMC Fam Pract; 2019 Jun; 20(1):82. PubMed ID: 31195985
[TBL] [Abstract][Full Text] [Related]
7. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study.
Villén N; Roso-Llorach A; Gallego-Moll C; Danes-Castells M; Fernández-Bertolin S; Troncoso-Mariño A; Monteagudo M; Amado E; Violán C
Geriatrics (Basel); 2022 Dec; 7(6):. PubMed ID: 36547277
[TBL] [Abstract][Full Text] [Related]
9. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Survival in relation to multimorbidity patterns in older adults in primary care in Barcelona, Spain (2010-2014): a longitudinal study based on electronic health records.
Ibarra-Castillo C; Guisado-Clavero M; Violan-Fors C; Pons-Vigués M; López-Jiménez T; Roso-Llorach A;
J Epidemiol Community Health; 2018 Mar; 72(3):185-192. PubMed ID: 29330165
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
Hasan Ibrahim AS; Barry HE; Hughes CM
Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.
Del Cura-González I; López-Rodríguez JA; Leiva-Fernández F; Gimeno-Feliu LA; Pico-Soler V; Bujalance-Zafra MJ; Domínguez-Santaella M; Polentinos-Castro E; Poblador-Plou B; Ara-Bardají P; Aza-Pascual-Salcedo M; Rogero-Blanco M; Castillo-Jiménez M; Lozano-Hernández C; Gimeno-Miguel A; González-Rubio F; Medina-García R; González-Hevilla A; Gil-Conesa M; Martín-Fernández J; Valderas JM; Marengoni A; Muth C; Prados-Torres JD; Prados-Torres A;
Trials; 2022 Jun; 23(1):479. PubMed ID: 35681224
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
[TBL] [Abstract][Full Text] [Related]
15. Medication-Related Problems in Older People with Multimorbidity in Catalonia: A Real-World Data Study with 5 Years' Follow-Up.
Troncoso-Mariño A; Roso-Llorach A; López-Jiménez T; Villen N; Amado-Guirado E; Fernández-Bertolin S; Carrasco-Ribelles LA; Borras JM; Violán C
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670201
[TBL] [Abstract][Full Text] [Related]
16. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.
von Buedingen F; Hammer MS; Meid AD; Müller WE; Gerlach FM; Muth C
BMC Fam Pract; 2018 Jul; 19(1):131. PubMed ID: 30055583
[TBL] [Abstract][Full Text] [Related]
17. Medication-related problems in older people in Catalonia: A real-world data study.
Troncoso-Mariño A; López-Jiménez T; Roso-Llorach A; Villén N; Amado-Guirado E; Guisado-Clavero M; Fernández-Bertolin S; Pons Vigues M; Foguet-Boreu Q; Violán C
Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):220-228. PubMed ID: 33026123
[TBL] [Abstract][Full Text] [Related]
18. Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns.
Vos R; Boesten J; van den Akker M
PLoS One; 2022; 17(2):e0264343. PubMed ID: 35213615
[TBL] [Abstract][Full Text] [Related]
19. Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China.
Zhang B; Wang J; Liu N; Liu W; Xi R; Wang P
BMC Nephrol; 2024 May; 25(1):169. PubMed ID: 38760750
[TBL] [Abstract][Full Text] [Related]
20. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
